Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amyris Inc    AMRS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

AMYRIS : Introduces EvoShieldTM Line of Industrial Lubricants

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/25/2011 | 02:10pm CET

Amyris, Inc. (NASDAQ:AMRS), a leading renewable chemicals and fuels company, today unveiled EvoShieldTM, its new product line of industrial lubricants. The announcement was made during a speech delivered by Amyris CEO John Melo at the Infineon Raceway of Sonoma's inaugural Accelerating Sustainable Performance Summit.

EvoShield lubricants are a family of renewably-sourced solutions designed to satisfy the most advanced lubrication challenges without compromising quality or performance. EvoShield lubricants will be formulated from NovaSpecTM renewably-sourced synthetic base oils, derived from Amyris's Biofene®and produced by Novvi, Amyris's joint venture with Brazil's Cosan.

"Novvi's high-performance base oils, combined with advanced additive systems, will enable Amyris EvoShield products to perform in a range of applications under extreme conditions of temperature, moisture, dirt and wear, while improving upon key environmental metrics including renewability, toxicity and biodegradability when compared with petroleum-sourced lubricants," said John Melo, CEO of Amyris. "We are on track to begin production this year and to redefine performance for the lubricants industry."

These lubricants will provide ideal protection for equipment across a broad range of industrial applications, including hydraulic, compressor, turbine and gear oils, as well as specific formulations for marine and food-grade requirements.

"The Infineon Summit provides the ideal environment and platform to announce our new line of renewably-sourced, high-performance industrial lubricants," said Jim Richardson, president of lubricants and fuels for Amyris. "Motorsports require the highest-performing products to deliver under challenging and extreme conditions. These performance expectations are consistent with the needs of our industrial customers in a variety of different applications and we're excited to introduce EvoShield's capabilities at an event that emphasizes sustainability and highlights our environmental improvements over petroleum-based lubricants."

As the Official Renewable Fuels Provider of the Raceway, Amyris also showcased the performance of its renewable diesel during the summit by powering a 2011 Audi Q7 TDI around the track. This demonstration marked the first on-road operation of a vehicle fueled by 100 percent neat Amyris renewable diesel.

Amyris is scaling its Biofene production in Brazil, Europe and the United States through five production arrangements, including manufacturing agreements with Antibióticos S.A., Biomin do Brasil Nutri?ão Animal Ltda., Paraíso Bioenergia S.A., Tate & Lyle and a joint venture with Usina São Martinho S.A., one of the largest sugar and ethanol producers in Brazil. Amyris has also established finishing capabilities with Glycotech, Inc. in North Carolina.

About Amyris, Inc.

Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules - flexible building blocks that can be used in a wide range of products. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. Amyris also has fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels, LLC. More information about Amyris is available at www.amyris.com.

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as statements regarding the performance attributes and environmental benefits of our lubricants products and the timing of their production) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, our reliance on third parties to achieve our goals, and other risks detailed in the "Risk Factors" section of Amyris's annual report on Form 10-K filed on March 14, 2011 and quarterly reports on Form 10-Q filed on May 11, 2011 and August 11, 2011. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Amyris, Biofene, EvoShield, and No Compromise are trademarks or registered trademarks of Amyris, Inc.

Schwartz Communications
Merrill Freund or Alison Mickey, 415-512-0770 (Press)
amyris@schwartzcomm.com


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AMYRIS INC
01:08p AMYRIS, INC. (NASDAQ : AMRS) Files An 8-K Creation of a Direct Financial Obligat..
12/09 AMYRIS, INC. : Creation of a Direct Financial Obligation or an Obligation under ..
12/08 AMYRIS : Findings from Amyris Inc. Provide New Insights into Anions [Engineering..
12/07 AMYRIS : Partners with Queensland to Create the leading Industrial Biotechnology..
12/06 Amyris Partners with Queensland to Create the leading Industrial Biotechnolog..
12/02 AMYRIS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct ..
12/01 Studies from Amyris Inc. Update Current Data on Cloning
12/01 AMYRIS : Global Oleochemicals Market - Genomatica, Myriant, Amyris, Solazyme, Go..
12/01 Amyris Signs Multi-Year Collaboration Extension with Kuraray
11/22 Amyris to Present at Four Upcoming Investor Conferences in December
More news
Sector news : Industrial Biotechnology Chemicals
11/17 JOHNSON MATTHEY : raises interim dividend by 5 percent
11/08DJHENKEL : Profit Boosted by Emerging Markets
10/31DJSIKA : Shares Soar as Court Backs Board's Opposition to Saint-Gobain Deal
10/30 COMPAGNIE DE SAINT GOBAIN : Sika family wants compromise talks in disputed Saint..
10/21 After Samarco delay, BHP's 'Jac the knife' to step down
More sector news : Industrial Biotechnology Chemicals
News from SeekingAlpha
12/09 Amyris (AMRS) presents at LD Micro Main Event
11/08 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Ohi, mdca, ftai, aat
11/03 ENERGY/MATERIALS - TOP 5 GAINERS / L : 00 pm
11/03 Midday Gainers / Losers
11/03 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
Advertisement
Financials ($)
Sales 2016 83,7 M
EBIT 2016 -63,8 M
Net income 2016 -63,2 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 2,51x
Capi. / Sales 2017 1,23x
Capitalization 210 M
More Financials
Chart AMYRIS INC
Duration : Period :
Amyris Inc Technical Analysis Chart | AMRS | US03236M1018 | 4-Traders
Full-screen chart
Technical analysis trends AMYRIS INC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 2,15 $
Spread / Average Target 169%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John G. Melo President, Chief Executive Officer & Director
Geoffrey M. Duyk Chairman
Raffi Asadorian Chief Financial Officer
Joel Cherry President-Research & Development
Louis John Doerr Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS INC-50.64%210
HENKEL AG & CO KGAA6.35%47 074
SIKA AG36.30%10 429
TRANSFAR ZHILIAN CO LT..--.--%9 239
SYMRISE AG-5.77%7 920
JOHNSON MATTHEY PLC14.60%7 411
More Results